PapersPMID:19937427
Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial.
What moved
1 findingHow to read these marks →- Decreases serum undercarboxylated osteocalcin concentration
very limitedreplicated ×2
“Serum levels of cOC increased and ucOC decreased in the treatment versus the placebo group (p < 0.001).”
- Study
- RCT
- Duration
- 12 months
- Dose studied
- 360 microg MK-7 in the form of Natto capsules, 12 months (dosing frequency not stated in the abstract); placebo was identical-looking olive-oil capsules
- Population
- Healthy Norwegian women aged 50-60 years, 1-5 years after menopause
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- healthy postmenopausal Norwegian women between 50 and 60 years, 1-5 years after menopause
- Participants
- 334
- Comparator
- placebo
- Duration
- 365 days
- Endpoints measured
- 6